AAOS 2024: Extracorporeal Shock Wave Therapy For Plantar Fasciitis: A Network Meta-Analysis .
Extracorporeal shock wave therapy versus other modalities for treatment of plantar fasciitis: a network meta-analysis
16 randomized controlled trials (1247 patients) comparing extracorporeal shock wave therapy (ESWT) against other treatment modalities (minimal dose ESWT, topical corticosteroids + ESWT, dextrose prolotherapy, platelet-rich plasma (PRP), corticosteroid injections (CSI), custom orthotics (CO), and placebo) were included in this network meta-analysis. The outcomes of interest included pain on a Visual Analog Scale (VAS), plantar fascia thickness (PFT), and total Foot Function Index (FFI) after 12 weeks. VAS scores were significantly better in the PRP group compared to ESWT. Similarly, PFT also favored the PRP group when compared to ESWT. Total FFI score was significantly better in the ESWT group compared to CSI.
Unlock the Full ACE Report
You have access to 4 more FREE articles this month.
Click below to unlock and view this ACE Reports
Unlock Now
Critical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidencecontent for as little as $1.99 per week.
Already have an account? Log in
0 of 4 monthly FREE articles unlocked
